Evidence map›Paper›PMID 22241987›Full record

ReviewPLoS pathogens2012

Type 1 interferons and antiviral CD8 T-cell responses.

Raymond M Welsh, Kapil Bahl, Heather D Marshall, Stina L Urban

Abstract readReview
In one paragraph

Review in PLoS pathogens, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 130 papers.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

130 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. R-loops: a key driver of inflammatory responses in cancer.Experimental & molecular medicine · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Microheterogeneity in the Kinetics and Sex-Specific Response to Type I IFN.Journal of immunology (Baltimore, Md. : 1950) · 2024
    Article
  18. Article
  19. Article
  20. Article

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Raymond M WelshDepartment of Pathology and Program in Immunology and Virology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America. Raymond.welsh@umassmed.edu
Kapil Bahl
Heather D Marshall
Stina L Urban

Funding

TRAINING IN IMMUNOLOGY (COMPETITIVE RENEWAL OF AI07439)T32AI007349 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J. · 1989 to 2024
$4.5M
Immunity and Virus DiseaseR37AI017672 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WELSH, RAYMOND M · 2004 to 2013
$4.0M
Virus induced immunopathologyR01AI081675 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WELSH, RAYMOND M · 2009 to 2013
$2.0M
NIAID NIH HHS R01 AI-081675NIAID NIH HHS R01 AI081675NIAID NIH HHS R37 AI-017672NIAID NIH HHS R37 AI017672NIAID NIH HHS T32 AI007349NIAID NIH HHS T32 AI07349
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Immunity, CellularAnimalsCD8-Positive T-LymphocytesHumansInterferon Type IVirus DiseasesVirusesInterferon Type I

Identifiers

PMID22241987
PMCPMC3252364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.